1-6 of 6
Federico Fallanca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Stephane Chauvie, Lale Kostakoglu Shields, Luca Guerra, Annibale Versari, Federico Fallanca, Michele Gregianin, Fabrizio Bergesio, Enrica Bergalla, Adriano De Maggi, Denis Sahin, Rexhep Durmo, Umberto Vitolo, Massimo Federico, Andrea Gallamini, Alessandro Rambaldi, Stefano Luminari
Journal: Blood
Blood (2024) 144 (Supplement 1): 7505.
https://doi.org/10.1182/blood-2024-205170
Published: 2024
Journal Articles

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Stephane Chauvie, Luca Guerra, Federico Fallanca, Michele Gregianin, Annibale Versari, Rexhep Durmo, Fabrizio Bergesio, Adriano De Maggi, Enrica Bergalla, Alessandro Rambaldi, Simone Ferrero, Caterina Patti, Massimo Federico, Andrea Gallamini, Stefano Luminari
Journal: Blood
Blood (2024) 144 (Supplement 1): 6254.
https://doi.org/10.1182/blood-2024-206736
Published: 2024
Journal Articles

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marco Foppoli, Stefania Girlanda, Marianna Sassone, Salvatore Perrone, Caterina Cecchetti, Fabio Ciceri, Claudio Bordignon, Angelo Corti, Nicoletta Anzalone
Journal: Blood
Blood (2019) 134 (3): 252–262.
https://doi.org/10.1182/blood.2019000633
Published: 2019
Includes: Supplemental data
Journal Articles

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Andres JM Ferreri, MD, Teresa Calimeri, MDPhD, Gian Marco Conte, MD, Dario Cattaneo, MD, Federico Fallanca, MD, Maurilio Ponzoni, MD, Eloise Scarano, Marianna Sassone, MD, Salvatore Perrone, MD, Caterina Cecchetti, MD, Paolo Lopedote, MD, Fiorella Ilariucci, Roberta Rudà, MD, Emanuele Angelucci, MD, Carlo Visco, Francesco Pisani, MD, Alberto Fabbri, MD, Luigi Petrucci, MD, Marco Bregni, MD, Dario Marino, MDPhD, Guido Gini, MD, Fabio Ciceri, MD, Angelo Corti, MD, Nicoletta Anzalone, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1687.
https://doi.org/10.1182/blood-2018-99-118507
Published: 2018
Journal Articles

The Prognostic Role of Interim PET after First Chemotherapy Cycle and PET Sequential Evaluation of Response to ABVD in Hodgkin Lymphoma Patients - the Polish Lymphoma Research Group (PLRG) Observational Study

Jan M Zaucha, MD PhD, Bogdan Malkowski, MD, Edyta Subocz, MD, Stephane Chauvie, PhD, Joanna Tajer, MD, Waldemar Kulikowski, MD, Agnieszka Fijolek-Warszewska, MD, Alberto Biggi, MD, Federico Fallanca, MD, Malgorzata Kobylecka, MD, Miroslaw Dziuk, MD PhD, Dariusz Woszczyk, MD, Justyna Rybka, MD, Renata Kroll-Balcerzak, MD, Fabrizio Bergesio, PhD, Agnieszka Romanowicz, MD, Agnieszka Chamier-Cieminska, MD, Pawel Kurczab, MD, Agnieszka Giza, Krzysztof Lesniewski-Kmak, MD, Wanda Knopinska-Posluszny, MD PhD, Jan Walewski, MDPhDProf, Andrea Gallamini, MD
Journal: Blood
Blood (2015) 126 (23): 3943.
https://doi.org/10.1182/blood.V126.23.3943.3943
Published: 2015
Journal Articles

Interim-PET Scan Interpretation In the Ongoing Prospective Clinical Trial HD 0607, In Advanced-Stage Hodgkin Lymphoma: Results of the the Expert Panel Review

Andrea Gallamini, MD, Alberto Biggi, MD, Stephane Chauvie, Alexandru Stancu, Federico Fallanca, Agostino Chiaravalloti, Michele Gregianin, Umberto Ficola, Ugo Guerra, Maria Rosaria Mennitto, Alessandro Rambaldi, MD
Journal: Blood
Blood (2010) 116 (21): 3891.
https://doi.org/10.1182/blood.V116.21.3891.3891
Published: 2010